Standard BioTools Inc. (LAB) P/S ratio

P/S ratio today
2.4×

Standard BioTools Inc. (LAB) trades at 2.4× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 5.7×. That is 15.6% lower than the 6.8× of fiscal 2024. Figures as of 17 Nov 2026, 21:13 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
2.4×
P/S ratio, fiscal 2025
5.7×
Change on fiscal 2024
−15.6%
Highest on record
6.8×fiscal 2024
Lowest on record
0.9×fiscal 2022
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Standard BioTools Inc. P/S ratio, in more detail

Today's figure is 57.9% below the fiscal 2025 year-end.

Across the 7 fiscal year-ends on record (2019–2025), the highest was 6.8× in fiscal 2024 and the lowest 0.9× in fiscal 2022. Today's P/S ratio is higher than at 57% of the 7 fiscal year-ends on record; their median is 2.3×.

History · 7 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Standard BioTools Inc. P/S ratio, year by year

Standard BioTools Inc. (LAB) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today2.4×—$0.54—
20255.7× 15.6% down$1.28$0.22
20246.8× 312.2% up$1.75$0.26
20231.6× 75.9% up$2.21$1.34
20220.9× 58.9% down$1.17$1.25
20212.3× 27.3% down$3.92$1.72
20203.1× 57.9% up$6.00$1.92
20192.0×—$3.48$1.76
2018——$8.62—
2017——$5.89—
2016——$7.28—
2015——$10.81—
2014——$33.73—
2013——$38.28—
2012——$14.31—
2011——$13.16—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on LAB

Standard BioTools Inc., figure by figure

Standard BioTools Inc. (LAB) overview: price, valuation and scorecard

Standard BioTools Inc. P/S ratio: questions and answers

What is Standard BioTools Inc.'s P/S ratio?

Standard BioTools Inc. (LAB) trades at 2.4× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 5.7×. That is 15.6% lower than the 6.8× of fiscal 2024.

Is Standard BioTools Inc.'s P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 57% of the 7 fiscal year-ends on record; their median is 2.3×.

What are the highest and lowest P/S ratio figures on record for Standard BioTools Inc.?

Across the 7 fiscal year-ends on record (2019–2025), the highest was 6.8× in fiscal 2024 and the lowest 0.9× in fiscal 2022.

How is Standard BioTools Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Standard BioTools Inc. (LAB) P/S ratio”, data as of 17 November 2026. https://funkfolio.com/stock/LAB/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.